Autopsy report · NCT04041037
The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series
Cause of deathFunding or business
“Sponsor Decision”
Life of this trial
- Registered 4 months after it had already started.
- Ran for about 7 months before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 8 months after it ended.
Vital statistics
- Status
- Terminated
- Sponsor
- Integra LifeSciences Corporation
- Sponsor type
- Industry
- Conditions
- Pilonidal Disease
- Interventions
- Wound Sheet Matrix 2-Layer and Powder Urinary Bladder Matrix
- Participants
- 2
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.